Skip to content

Globalex Pharma OÜ

Registry code (registrikood) 11505401Private limited company (Osaühing)VAT EE101258939Activity (EMTAK 46461): Ravimite ja muude apteegikaupade hulgimüükActive

Tallinn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€16.1M
▲ 50.7% vs 2024
Profit before tax (2025)
€637k
Employees, FTE (2025)
4
State taxes paid, last 4 quarters
€363k

Revenue, profit and employees, 2019–2025

€1.1M2019€1.6M2020€1.8M2021€7.9M2022€7.5M2023€10.7M2024€16.1M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2019€1,099,674€69,596€65,798€228,6301
2020€1,610,898€94,081€88,582€317,2121
2021€1,832,803-€33,086-€87,206€230,0062
2022€7,899,136€267,754€252,806€482,8112
2023€7,483,651€243,218€238,395€721,2063
2024€10,682,780€423,309€434,336€1,155,5424
2025€16,102,894€555,717€637,153€1,792,6954

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2019€8,719€317,133€88,503—€228,630
2020€8,579€494,378€177,166—€317,212
2021€207€755,239€438,944€86,289€230,006
2022€64,408€933,063€423,395€26,857€482,811
2023€521,765€1,132,449€388,950€22,293€721,206
2024€920,063€2,303,262€1,130,991€16,729€1,155,542
2025€844,687€5,312,425€3,519,730€0€1,792,695

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€978€2,872€1,817,7283
2022 Q2€0€3,104€2,214,0873
2022 Q3€210,591€4,457€1,422,3573
2022 Q4€0€6,242€3,551,3094
2023 Q1€44,993€6,207€1,547,5774
2023 Q2€37,765€6,067€574,8674
2023 Q3€52,931€7,357€2,153,0965
2023 Q4€50,114€8,687€2,912,1565
2024 Q1€32,013€7,989€452,7045
2024 Q2€44,190€8,370€1,021,7035
2024 Q3€48,514€8,580€2,286,2265
2024 Q4€122,890€9,990€4,132,2855
2025 Q1€77,724€10,908€5,853,9485
2025 Q2€15,559€11,422€4,132,9584
2025 Q3€82,454€12,201€10,184,1865
2025 Q4€46,285€10,288€3,678,9845
2026 Q1€101,303€10,624€5,634,4115
2026 Q2€90,252€10,762€4,943,8025
2026 Q3€125,454€10,454€6,340,9975

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), Globalex Pharma OÜ reported revenue of €16,102,894.

The company closed the 2025 financial year with a net profit of €637,153.

Revenue increased by 50.7% from €10,682,780 in 2024 to €16,102,894 in 2025.

Revenue grew at a compound annual rate of 56.4% between 2019 and 2025.

Equity accounted for 33.7% of total assets of €5,312,425 at the end of the 2025 reporting period.

With 4 full-time-equivalent employees in 2025, revenue per employee was €4,025,724.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, Globalex Pharma OÜ reported €20,598,194 in turnover.

EMTA recorded 5 employees for the quarter ending Q3 2026, compared with 4 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.